CTRI/2020/02/023319尚未招募未知
Biomarker enhanced management of acute kidney injury in Indian patients - BEMAKI
BioMerieux India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age > 18 admitted to ICUs
- •Diagnosis of sepsis or following major surgery.
- •High risk of developing AKI based on the Malhotra score > 88
排除标准
- •Unable to give consent and absence of any surrogate to give consent
- •Chronic hemodialysis or peritoneal dialysis within the past 12 months
- •Functioning kidney transplantation
- •Patients not expected to survive more than 48 h
研究者
相似试验
已完成
不适用
Investigating biomarkers for acute kidney injury (AKI) progression after cardiac surgery associated AKIN17Acute renal failureDRKS00021435niversitätsklinikum MünsterKlinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie100
已完成
不适用
Biomarker-guided Intervention to Prevent Acute Kidney InjuryAcute Kidney InjuryNCT04647396University Hospital Muenster1,180
已完成
不适用
Biomarker-guided Implementation of the AKI BundleAcute Kidney Injury (Nontraumatic)NCT03244514University Hospital Muenster280
已完成
不适用
What is the best biomarker to predict acute kidney injury during living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014282Toho University School of Medicine , Department of Anesthesiology30
已完成
不适用
Prevention of Acute Kidney Injury Through Biomarker-guided Nephrological InterventionAcute Kidney InjuryNCT02730637Robert Bosch Medical Center100